Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
Institut de Recherches Expérimentales et Cliniques, Université catholique de Louvain, Brussels, Belgium.
Radiother Oncol. 2014 Nov;113(2):204-9. doi: 10.1016/j.radonc.2014.09.016. Epub 2014 Nov 27.
Hypoxia-driven intervention (oxygen manipulation or dose escalation) could overcome radiation resistance linked to tumor hypoxia. Here, we evaluated the value of hypoxia imaging using (18)F-FAZA PET to predict the outcome and guide hypoxia-driven interventions.
Two hypoxic rat tumor models were used: rhabdomyosarcoma and 9L-glioma. For the irradiated groups, the animals were divided into two subgroups: breathing either room air or carbogen. (18)F-FAZA PET images were obtained just before the irradiation to monitor the hypoxic level of each tumor. Absolute pO2 were also measured using EPR oximetry. Dose escalation was used in Rhabdomyosarcomas.
For 9L-gliomas, a significant correlation between (18)F-FAZA T/B ratio and tumor growth delay was found; additionally, carbogen breathing dramatically improved the tumor response to irradiation. On the contrary, Rhabdomyosarcomas were less responsive to hyperoxic challenge. For that model, an increase in growth delay was observed using dose escalation, but not when combining irradiation with carbogen.
(18)F-FAZA uptake may be prognostic of outcome following radiotherapy and could assess the response of tumor to carbogen breathing. (18)F-FAZA PET may help to guide the hypoxia-driven intervention with irradiation: carbogen breathing in responsive tumors or dose escalation in tumors non-responsive to carbogen.
缺氧驱动干预(氧处理或剂量递增)可以克服与肿瘤缺氧相关的放射抵抗。在这里,我们评估了使用 (18)F-FAZA PET 进行缺氧成像来预测结果和指导缺氧驱动干预的价值。
使用两种缺氧大鼠肿瘤模型:横纹肌肉瘤和 9L 胶质细胞瘤。对于接受照射的组,动物被分为两组:呼吸空气或卡波贡。在照射前获得 (18)F-FAZA PET 图像,以监测每个肿瘤的缺氧水平。还使用 EPR 血氧计测量绝对 pO2。在横纹肌肉瘤中使用剂量递增。
对于 9L 胶质细胞瘤,发现 (18)F-FAZA T/B 比值与肿瘤生长延迟之间存在显著相关性;此外,卡波贡呼吸显著改善了肿瘤对放疗的反应。相反,横纹肌肉瘤对高氧挑战的反应较差。对于该模型,使用剂量递增观察到生长延迟增加,但与卡波贡联合使用照射时则没有。
(18)F-FAZA 摄取可能是放疗后预后的预测指标,并可评估肿瘤对卡波贡呼吸的反应。(18)F-FAZA PET 可能有助于指导放疗的缺氧驱动干预:对有反应的肿瘤进行卡波贡呼吸,或对不响应卡波贡的肿瘤进行剂量递增。